James Waisman Selected Research

James Waisman Research Topics

Disease

25	Breast Neoplasms (Breast Cancer) 02/2023 - 03/2008
16	Neoplasms (Cancer) 02/2024 - 03/2008
4	Triple Negative Breast Neoplasms 04/2024 - 01/2021
2	Pathologic Complete Response 04/2024 - 04/2014
2	Hyperglycemia 02/2023 - 01/2023
2	Cognitive Dysfunction 01/2020 - 10/2012
2	Neoplasm Metastasis (Metastasis) 07/2017 - 01/2017
1	Exanthema (Rash) 09/2022
1	Lymphopenia (Lymphocytopenia) 09/2022
1	Diarrhea 01/2021
1	Residual Neoplasm 01/2021
1	Neutropenia 04/2018

Drug/Important Bio-Agent (IBA)

6	Hormones (Hormone)IBA 01/2023 - 10/2012
4	pembrolizumabIBA 04/2024 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 02/2020 - 01/2017
3	CytokinesIBA 02/2020 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 10/2017 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2008
2	LigandsIBA 02/2024 - 01/2017
2	GlucocorticoidsIBA 02/2023 - 10/2012
2	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 01/2021
2	palbociclibIBA 01/2021 - 04/2018
2	130-nm albumin-bound paclitaxelIBA 01/2021 - 07/2017
2	human ERBB2 proteinIBA 04/2018 - 10/2009
2	fibrin fragment D (D-dimer)IBA 10/2017 - 08/2017
2	Blood Coagulation Factors (Coagulation Factor)IBA 10/2017 - 08/2017
2	Trastuzumab (Herceptin)FDA Link 04/2014 - 10/2009
2	VaccinesIBA 02/2014 - 10/2009
1	Blood Glucose (Blood Sugar)IBA 02/2023
1	Glucose (Dextrose)FDA LinkGeneric 02/2023
1	SteroidsIBA 02/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2023
1	taxaneIBA 02/2023
1	atezolizumabIBA 01/2023
1	ipatasertibIBA 01/2023
1	AlpelisibIBA 01/2023
1	Capecitabine (Xeloda)FDA Link 01/2023
1	Fulvestrant (Faslodex)FDA Link 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	Immune Checkpoint InhibitorsIBA 09/2022
1	ErbB Receptors (EGF Receptor)IBA 09/2022
1	Aromatase InhibitorsIBA 09/2022
1	neratinibIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	PlatinumIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	ostarineIBA 01/2021
1	IronIBA 12/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	C-Reactive ProteinIBA 10/2017
1	Imiquimod (Aldara)FDA LinkGeneric 07/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2017
1	Albumin-Bound Paclitaxel FDA Link 07/2017
1	ChemokinesIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Neutralizing AntibodiesIBA 01/2017
1	pertuzumabIBA 04/2014
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2012
1	Leuprolide (Lupron)FDA LinkGeneric 10/2012
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2009
1	AntigensIBA 10/2009
1	Peptides (Polypeptides)IBA 10/2009
1	EpitopesIBA 10/2009
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2008

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 02/2023 - 04/2014
8	Therapeutics 01/2021 - 03/2008
5	Adjuvant Chemotherapy 07/2019 - 10/2017
2	Neoadjuvant Therapy 04/2024 - 01/2021
2	Drug Tapering 01/2021 - 04/2018
1	Metastasectomy 08/2022
1	Activities of Daily Living (ADL) 10/2017
1	Modified Radical Mastectomy (Mastectomy, Modified) 04/2014